Eastgate Financial Statements From 2010 to 2024

ETBIDelisted Stock  USD 0  0.00  0.00%   
Eastgate Biotech financial statements provide useful quarterly and yearly information to potential Eastgate Biotech Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Eastgate Biotech financial statements helps investors assess Eastgate Biotech's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Eastgate Biotech's valuation are summarized below:
Eastgate Biotech Corp does not presently have any fundamental signals for analysis.
Check Eastgate Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eastgate Biotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Eastgate financial statements analysis is a perfect complement when working with Eastgate Biotech Valuation or Volatility modules.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Eastgate Biotech Corp Company Price To Earning Analysis

Eastgate Biotech's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

 = 

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis

Current Eastgate Biotech Price To Earning

    
  (0.10) X  
Most of Eastgate Biotech's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eastgate Biotech Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition

Based on the latest financial disclosure, Eastgate Biotech Corp has a Price To Earning of -0.1 times. This is 100.39% lower than that of the Healthcare sector and significantly lower than that of the Pharmaceuticals industry. The price to earning for all United States stocks is 100.35% higher than that of the company.

Eastgate Biotech Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Eastgate Biotech's current stock value. Our valuation model uses many indicators to compare Eastgate Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eastgate Biotech competition to find correlations between indicators driving Eastgate Biotech's intrinsic value. More Info.
Eastgate Biotech Corp is one of the top stocks in operating margin category among its peers. It also is rated as one of the top companies in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eastgate Biotech's earnings, one of the primary drivers of an investment's value.

About Eastgate Biotech Financial Statements

Investors use fundamental indicators, such as Eastgate Biotech's revenue or net income, to determine how well the company is positioned to perform in the future. Although Eastgate Biotech's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. Eastgate Biotech Corp. was founded in 1999 and is based in Toronto, Canada. EASTGATE BIOTECH is traded on OTC Exchange in the United States.

Currently Active Assets on Macroaxis

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Consideration for investing in Eastgate Stock

If you are still planning to invest in Eastgate Biotech Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eastgate Biotech's history and understand the potential risks before investing.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities